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ABSTRACT 
Background: The modern western diet has been one of the major suspects in the rise of chronic disease 
such as diabetes, cardiovascular disease, and obesity. The Paleolithic diet may be a more metabolic fit 
for humans compared to current contemporary diets. The purpose of this review is to investigate the 
effects of a Paleolithic diet on the risk factors of patients with chronic disease in isolation and compared 
to contemporary diets. 
Methods: An exhaustive search of online medical literature was performed using Medline-OVID, Web of 
Science, and CINAHL-EBSCO. Keywords used included: Paleolithic diet, palaeolithic diet, paleo diet, and 
hunter gatherer diet. Eligible studies were assessed using the GRADE criteria. 
Results: Four articles met eligibility criteria. Two of the articles were by the same author discussing the 
same study but with different data that are relevant to this review. Two of studies were randomized 
control trials while one was specifically a randomized crossover trial. There are some consistent results 
regarding significant improvement of weight, waist circumference, and triglycerides in the Paleolithic 
diet groups when compared to the contemporary diet groups. The overall quality of the original studies 
are low to moderate due to some limitations. Further studies can minimize these limitations to improve 
quality of evidence in regards to the effects of a Paleolithic diet on patients with chronic disease. 
Conclusion: Thus far, studies investigating a Paleolithic diet do not provide enough evidence to support 
its place as a universally recommended diet, but the diet can be an option for medical providers to 
discuss with patients to combat chronic disease. 
Keywords: Paleolithic diet, palaeolithic diet, chronic disease, diabetes, obesity, cardiovascular disease, 
risk factors 
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The effects of a Paleolithic diet on the risk factors of chronic disease 
 
BACKGROUND 
 Chronic diseases such as diabetes, obesity, and cardiovascular disease have been shown to be 
major causes of comorbidities and mortalities in the Western world.1 For example, diabetes was the 
seventh leading cause of death in the United States in 2010, and it may even possibly be underreported 
as a cause of death. Diabetes has many complications if left untreated, including lack of blood sugar 
control, hypertension, dyslipidemia, rising risk of heart attack and stroke, diabetic retinopathy, and 
kidney disease.2 In addition to lack of exercise and exposure to environmental chemicals such as 
cigarette smoke, poor nutrition has been a main cause in the rise of chronic disease.  
 The human diet has changed drastically ever since the agricultural revolution (Neolithic era) 
after the Paleolithic era.3 Humans have not evolved at the same pace to adequately metabolize the food 
that is in excess in the modern world and was scarce in the Paleolithic era. For example, while the vast 
majority of the Paleolithic diet (PD) of hunter-gatherers involved lean meat, fish, fruits, vegetables, and 
nuts, an average 64.7% of the American diet is made up of sugars, fats and oils, and grain products.4,5 
 There have been short-term studies of healthy human subjects that have shown improvement 
with some chronic disease risk factors after being on a PD.6,7 In Osterdahl et al,6 observation of 14 
healthy volunteers on the PD for 3 weeks showed significant decreases in weight, waist circumference, 
and systolic blood pressure (SBP) from baseline. In Frassetto et al,7 nine non-obese sedentary healthy 
volunteers were on the PD for 10 days which resulted in significant decreases in their diastolic blood 
pressure (DBP) and mean arterial pressure (MAP) from baseline. 
 In addition to increased physical exercise and abstinence from harmful environmental 
chemicals, many diets have been offered as a solution to combating chronic disease, whether they are 
clinically recommended or not. Osterdahl et al6 and Frassetto et al7 has provided some evidence in 
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support of the PD improving several chronic disease risk factors in healthy participants. The aim of this 
review is to find out if the Paleolithic diet can significantly reduce risk factors of patients with chronic 
disease in isolation and when compared to contemporary diets. 
METHODS 
An exhaustive online search of medical literature was performed using MedLine-OVID, Web of 
Science, and CINAHL-EBSCO databases. The keywords used during this search were: paleolithic diet, 
paleo diet, palaeolithic diet, and hunter gatherer diet. Eligibility criteria were: English language articles, 
randomized trials, studies using human subjects, inclusion criteria participants with chronic disease, 
measures of cardiovascular disease, diabetes, and obesity were used as outcome variables, and the 
Paleolithic diet was compared contemporary diets. An altered version of the Paleolithic diet was not 
considered a contemporary diet. Applicable articles were assessed for quality using the Grading of 
Recommendations, Assessment, Development, and Evaluation (GRADE).8 
RESULTS 
An initial search of Medline-OVID using the aforementioned keywords revealed 45 articles. 
Three articles9,10,11 met eligibility criteria. It is important to note that two9,10 of these three articles are 
based on the same study with data completed from the same patient population. The main difference 
from the original study by Lindeberg et al9 and the second article10 published in 2010 by mostly the same 
authors was the separate sets of data that were discussed. Both articles were included in this review 
since they contain different outcome variables that are relevant for this systematic review. An initial 
search of Web of Science with the keywords resulted in 421 articles of which six were randomized trials. 
One of these articles12 met eligibility criteria and did not appear in the Medline-OVID search. A search of 
CINAHL-EBSCO with the keywords revealed 39 articles of which none met eligibility criteria and was 
exclusive to CINAHL compared to the aforementioned database searches. In total, four articles were 
assessed for this systematic review (See Table I). 
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Lindeberg et al (2007) 
 This 12 week randomized control trial9 was designed to compare patients with ischemic heart 
disease (IHD) with either type 2 diabetes or glucose intolerance and a waist circumference of >94 cm 
randomized to the PD or Mediterranean-like (Consensus) diet. Primary outcome variables focused on 
glucose intolerance. All participants were patients recruited from the Coronary Care Unit at Lund 
University Hospital in Sweden. Inclusion criteria was ongoing coronary syndrome, a diagnosed history of 
myocardial infarction, diagnosed coronary stenosis of >30% by angiogram, and percutaneous coronary 
intervention or coronary artery bypass surgery. Patients were excluded if they had a BMI <20 kg/m2, 
serum creatinine >130 μmol/l, poor general condition, dementia, unwillingness/inability to prepare food 
at home, participation in another trial, chronic inflammatory bowel disease, type 1 diabetes and 
treatment with hypoglycemic agents, warfarin or oral steroids. Out of 38 eligible subjects, 29 male 
patients were included in the study after the other nine were excluded due to worsening general 
condition (n = 4), unwillingness to continue (n = 3, all from the PD group), or missing oral glucose 
tolerance test (OGTT) data (one in each group). Eligible participants were informed about the intent to 
compare two healthy diets but were not told if one was superior to the other in reducing weight or 
improving glucose tolerance.9 
 Twenty-nine subjects were randomized into a PD group (n = 14) and Consensus group (n = 15). 
Before the study, the authors calculated that 12 patients would be needed in each group in order to 
detect, with a 80% power and at a significance level of 5%. The PD was based on lean meat, fish, fruits, 
leafy and cruciferous vegetables, root vegetables (including restricted amounts of potatoes), eggs and 
nuts while the Consensus diet was based on whole-grain cereals, low-fat dairy products, potatoes, 
legumes, vegetables, fruits, fatty fish and refined fats rich in monounsaturated fatty acids and alpha-
linolenic acid. Both groups were prognostically balanced except for a difference (p-value = 0.01) of age 
in years where the PD group was older (65 +/- 10) than the Consensus group (57 +/- 7). Both groups 
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were given dietary advice, food recipes, and information on the main concepts of their specified diet. 
Both groups had small differences in education intensity pertaining to their diet and were advised about 
regular physical activity in an equal fashion. Due to the small difference in dietary education provided to 
both study groups, the authors did not consider a “usual care” control group necessary. There was no 
mention of blinding in the article.9 
 Primary endpoints decided on before the start of the study were changes in the area under the 
curve between 0 and 120 minutes during OGTT for plasma glucose (AUC Glucose0-120) and plasma insulin 
(AUC Insulin0-120), along with changes in body weight and waist circumference. Diet surveillance was 
done with a single 4 consecutive day weighted food record that included a weekend day. This was done 
15 +/- 5 days after the initiation of diet change. Patients were given a digital weighing scale, with a 
zeroing function, to weigh their food. The authors checked for under-reporting by comparing food 
records with baseline weight and achieved weight loss, and by evaluating distribution and amount of 
consumed food.9 
 Results were analyzed with a confidence interval of 95% and significant p-value of <0.05 (See 
Table II). There was no significant differences between study groups in weight loss at 6 weeks from 
baseline or 12 weeks from baseline although both had significant weight loss within their groups at the 
aforementioned checkpoints. Decrease of waist circumference was significant within both groups at 6 
and 12 weeks from baseline while the PD group had a significant decrease compared to the Consensus 
group at the same checkpoints. AUC Glucose0-120 and AUC Insulin0-120 were both significantly decreased 
within the PD group at 6 weeks and 12 weeks from baseline. The same measures were not significant 
within the Consensus group except for a significant decrease of AUC Insulin0-120 at 6 weeks from 
baseline. The PD group had a significant decrease of AUC Glucose0-120 compared to the Consensus diet at 
12 weeks from baseline while there was no significant difference of AUC Insulin0-120 between groups at 
the same checkpoint. Decrease in fasting plasma glucose was significant within the PD diet at 12 weeks 
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from baseline while the same measure was insignificant in the Consensus diet but there was no 
significant difference between the groups. There was no significant decrease of HbA1C within or 
between study groups at 6 or 12 weeks from baseline.9 
 Limitations of this study include a dropout of nine eligible participants though they were not 
part of the intention to treat patients and the method of randomization was not noted in the article. 
Although there was a check for underreporting of diet adherence, only one 4 consecutive day diet 
report was used with each participant for the duration of the 12 weeks.9 
Jönsson et al (2010) 
 This article is a review of the trial done by Lindeberg et al9 in which the majority of the same 
authors of the original study discuss results that were not included in the first published article. These 
results of the second article pertain to data of subjective ratings of satiety at meals, fasting plasma 
leptin, plasma leptin receptor, and free leptin index drawn from the same PD and Consensus groups. 
Satiety data was based on a Satiety Quotient. The Satiety Quotient is calculated by the difference of 
satiety ratings pre-eating episode and post-eating episode divided by food intake of the eating 
episode.13 The relevance of including the hormone, leptin in the study is due to its effects on appetite, 
blood pressure, and energy homeostasis among other applications.14 Leptin binds to soluble leptin 
receptors (SLR) which play a major role in activation of leptin.15,16 Free leptin index (“ratio of levels of 
circulating leptin and SLR”) has been shown to have a positive correlation with risk factors such as body 
fat mass and hypertension.17,18 Refer to above9 in regards to overall study methods and limitations of 
the original study. 
 There was no significant difference in change of satiety after meals between the PD and 
Consensus groups but the PD group had a significantly lower mean average of energy from food and 
drink per meal as well as per day compared to the Consensus group. Increase in fasting plasma leptin 
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was significantly higher within both groups at 6 and 12 weeks from baseline. Relative change in fasting 
plasma leptin was only significantly higher in the PD group compared to the Consensus group at 6 and 
12 weeks from baseline when one outlier was excluded. There was no significant difference in the 
relative change of fasting plasma leptin receptors between groups at 6 or 12 weeks from baseline. There 
was no significant difference in relative changes of free leptin index between both groups at 6 or 12 
weeks from baseline. Relative changes in leptin and changes in weight and waist circumference 
correlated significantly in the PD group but not in the Consensus group. The data of improved glucose 
tolerance in the original study did not correlate with the new data regarding satiety, leptin, or leptin 
receptors.10 
Jönsson et al (2009) 
 This was a separate study done by mostly the same authors of Lindeberg et al in 2007. It was a 
randomized cross-over comparison of type 2 diabetes patients (not being treated with insulin) assigned 
to either the PD or Diabetes diet (based on current recommendations19) groups initially with 
cardiovascular risk factors as the outcomes variables. The study length was 6 months with patients 
switching their initially assigned of diets after the end of 3 months to the other diet. There was no 
washout period before the crossover. Participants were recruited from three primary health care units 
in the Lund area in Sweden. Inclusion criteria was type 2 diabetes, C-peptide value above zero, unaltered 
medical diabetes treatment and stable weight for since three months before start of study, HbA1C 
above 5.5%, creatinine below μmol/L, liver enzymes below their respective upper reference values, no 
chronic oral or injection steroid treatment and no acute coronary event or change in beta blockers or 
thyroxin since six months before start of study. Patients were excluded during the process of the study if 
they had changes or addition to the aforementioned medications, creatinine and liver enzymes 
increasing above the aforementioned values, receiving warfarin treatment, an acute coronary event, 
physical or psychological illness, or circumstances preventing them from completing the study. 
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Exceptions to the exclusion in regards to medication changes during the study were made to pertaining 
patients if their removal would have not changed the outcome data.11  
 Out of 17 eligible patients, 13 (10 men and 3 women) were included in the study. The other four 
patients were excluded due to either: being included incorrectly because of ongoing warfarin treatment, 
unwilling to continue due to GI symptoms, development of leukemia, or development of heart failure. 
Prior to the study, it was calculated that a total of 15 patients would be required to detect, with a 80% 
power and at significance level of 5%. As with Lindeberg et al9, participants were not given any 
information regarding a superior diet and the goal of patient education in both diets was to be equal as 
much as possible to prevent bias. Seven patients were randomized to the PD while six were randomized 
to the Diabetes diet. Randomization was done using identical envelopes for both diets. No blinding was 
done on participants or investigators of the study after randomization. No control group was included in 
the study as each participant were their own control as they had an equal trial length of both diets (3 
months). Both groups were prognostically balanced except the group starting with the PD had a lower 
baseline HbA1C (p-value = 0.06), significantly lower baseline fasting plasma glucose (p-value = 0.02), and 
significantly lower baseline AUC glucose0-120 (p-value = 0.046). As mentioned above, no washout period 
was performed in this study but mean values of outcome variables and reported dietary intakes for the 
group starting with Paleolithic diet was compared with the group starting with Diabetes diet in order to 
check for carry-over effects. As with Lindeberg et al9, a four consecutive day weighed food record was 
done by each patient in the same manner except that one was done 6 weeks after starting each diet.11  
 Outcome variables for this study included HbA1C, cholesterol, LDL levels, HDL levels, 
triglycerides (TG), systolic blood pressure (SBP), diastolic blood pressure (DBP), weight, body mass index 
(BMI), waist circumference, fasting plasma glucose, fasting plasma insulin, AUC Glucose0-120, and AUC 
Insulin0-120. At the end of the three months from baseline, the group that started with the PD had a more 
significant relative decrease HbA1C, TG, DBP, weight, BMI, and waist circumference with a more 
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significant relative increase in HDL when compared to the group that started with the Diabetes diet. 
There was no significant difference between groups in regards to relative change of cholesterol, LDL, 
SBP, fasting plasma glucose, fasting plasma insulin, AUC Glucose0-120, and AUC Insulin0-120 at the end of 
three months from baseline. At the end of six months, there were no significant differences in 
cholesterol, LDL, HDL, TG, Weight, BMI, waist circumference, SBP, DBP, fasting plasma glucose, or fasting 
plasma insulin between the two groups. Possible carryover effects were noted with the measurement of 
HbA1C at six months from baseline as the group starting with the PD had a significantly lower value than 
the comparison group. No carry-over effects were found in reported dietary intake although this 
particular data was not shown in the article.11  
 Limitations of this study include lack of blinding after randomization and a small patient 
population that was lower than the pre-study power calculation. Similarly to Lindeberg et al,9 only a 
single four consecutive day diet report was used with each participant for each three month period. 
Mellberg et al (2014) 
 This was a randomized control trial12 that compared 70 obese postmenopausal women on either 
a PD or Nordic Nutrition Recommendations (NNR) diet20 for two years. The primary outcome was 
change in fat mass. Recruitment was done through advertisements of local newspapers of which 210 
women were interested in study participation. Additional inclusion criteria were no smoking and a BMI 
of equal or greater than 27 kg/m2. Subjects were excluded if they were on a restricted or vegetarian 
diet, had allergies to important foods of the study diets, had a history of heart disease, kidney disease, 
thyroid disease, osteoporosis, diabetes, abnormal fasting plasma glucose levels, high blood pressure, on 
hormone replacement therapy, taking beta-blockers, statins, or any medication for mental health 
disorders.12  
Page 14 of 21 
 
 The study authors estimated a significant outcome (p <0.05) with 80% power would require at 
least 35 subjects in each diet group. Block randomization was done by a statistician blinded to the study. 
All study personnel (except the dieticians) were blinded to the dietary allocation of the participants. One 
trained dietician per diet held 12 educational group sessions with their respective diet group throughout 
the 2 year period. Data was assessed with an intention-to-treat analysis. Both groups were 
prognostically balanced except for higher HDL in the PD group (p = 0.01).12 
 There was a significant decrease of fat mass, body weight, waist circumference, and sagittal 
abdominal diameter in the PD group compared to the NNR group at 6 months from baseline. There was 
no significant difference between groups with the same anthropometric measures at 24 months from 
baseline. The PD group showed a significant decrease in TG at 6 and 24 months from baseline when 
compared to the NNR group. This was not true for other outcome variables in the study, including 
fasting insulin, glucose, SBP, DBP, cholesterol, HDL, and LDL.12 
 Limitations of the study includes the high dropout rate in both groups at 6 month (nPD = 1 and 
nNNR = 8) and 12 month follow-up (nPD = 7 and nNNR = 5) which resulted in a study population that was 
lower than the required 35 subjects in each diet estimated to have a p <0.05 at 80% power. In addition, 
there was no third (control) group to compare to both the PD and NNR groups.12 
DISCUSSION 
 The modern western diet has been one of several major societal factors attributed to the 
increase in chronic disease in modern civilization. More specifically, the increase of surplus in foods that 
were scarce before the industrialized world and especially before the agricultural revolution, has been 
faster than what the human body can adjust to metabolize adequately.3 There have been some 
evidence to show that a diet more closely resembling that of what a hunter-gatherer consumed in the 
period before the agricultural revolution, the Paleolithic era can help decrease risk factors of chronic 
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disease.6,7 These benefits are generally held consistent with the studies9-12 of this systematic review. 
Although the overall quality of these studies is low to moderate, the possibly strong advantages of the 
Paleolithic diet outweigh its low risk of harm. Thus, clinicians should consider possibly recommending 
the PD to patients with chronic diseases such as diabetes, obesity, and cardiovascular disease. 
 In the three reviewed original studies, decrease in weight and/or waist circumference was 
significant within the PD groups across the studies.9,11,12 The same measures were significant between 
study groups of Jönsson et al (2009)11 at three months from baseline and Mellberg et al12 at six months 
from baseline. The authors of Mellberg et al12 proposed that lack of significance in these measures 
between intervention diets at 24 months may be due to patients of the PD group having decreased 
adherence to their diet in the long term. This may be due to lack of motivation and financial burden of 
the Paleolithic diet’s main foods (such as lean meats, fruits, and vegetables).12 Lack of significance 
between dietary interventions in Lindeberg et al9 for weight loss and waist circumference may indicate 
that a Mediterranean (Consensus) diet has more similar strength of effect on such outcomes to a PD 
than a Diabetic or NNR diet.  
 Fasting plasma glucose and fasting plasma insulin decreased within the PD groups of all three 
studies9,11,12 with only Mellberg et al12 showing no significance in either measure, though this may be 
due to the pertaining subjects having a normal glucose tolerance at baseline. This is supported as both 
PD and NNR groups were prognostically balanced overall. Furthermore, the NNR group also showed no 
significant decrease of fasting plasma glucose and fasting plasma insulin within the diet group.12 There 
was no significant relative decrease of plasma glucose between the PD and the other contemporary 
diets in all three studies.9,11,12  
 The findings discussed in Jönsson et al (2010)10 showed a similar mean satiety ratings between 
dietary groups with the PD group consuming less energy from food and drink. The importance of this 
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finding is that PD foods can be more satiating than recent dietary recommendations for diabetes 
patients. This can possibly have implications on helping diabetic patients improving their glucose 
intolerance through weight loss from eating less calories with more satiating foods in the PD.10 
 A full lipid panel of outcomes (cholesterol, HDL, LDL, and TG) was measured in only Jönsson et al 
(2009)11 and Mellberg et al.12 Of these outcomes, only TG showed consistent results between the two 
studies in regards to a relative significant improvement between the PD group and contemporary diet 
groups. This may be due to the difference of the contemporary diets (in this case, Diabetic diet and NNR 
diet). Nonetheless, there is an improvement in cholesterol, HDL, LDL, and TG within the PD group in 
both studies, though not each outcome was significant.11,12  
The main limitations of the studies included in this systematic review are lack of double-
blinding, lack of true control groups to the intervention diets, small study population size, and attrition 
bias.9-12 Specifically in Jönsson et al (2009),11 the lack of a washout period possibly resulted in carryover 
effects of HbA1C in this randomized cross-over trial although there was no carryover effects for the 
dietary intake change (See Table I). This shows the participants adhering to the diets but it was only 
based on a single four consecutive day diet intake report. In addition, a washout period would have 
given a more clear effect of the PD on HbA1C levels in both groups as this variable is essentially a 
biomarker of blood sugar levels within the past 2 to 3 months. Generally, double-blinding in dietary 
studies are difficult to perform as subjects can easily distinguish between the key components of diets, 
especially with the guidance of study dieticians. Further studies can minimize this by blinding 
investigators who are involved with data collection. Control groups can be hard to implement as there is 
no “universal consensus diet” as well as a lack of utility in comparing healthy patients and those with 
chronic disease. The authors of the reviewed studies tried to minimize the lack of blinding and control 
groups by equalizing the patient education between diet interventions as much as possible.9-12 An 
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alternative to using a vague “control diet group” is to have several contemporary diets (more than one) 
to compare to the PD in one single study. 
CONCLUSION 
 There is some evidence presented in observational studies of healthy patients and RCTs of 
patients with chronic disease that a Paleolithic diet can improve various risk factors of diabetes, 
cardiovascular disease, and obesity. Furthermore, the Paleolithic diet has shown to be as effective or 
more effective in improving many of these risk factors in comparison studies with contemporary diets. 
This current collective evidence is not strong enough to change dietary guidelines for patients with 
chronic disease due to several limitations in the reviewed studies. Future studies should have outcome 
measurements for both short term (<3 months) and long-term (>1 year) checkpoints, at least two 
common contemporary diets to compare to the PD, maximized blinding per a diet comparison model, 
and regular intervals of patients recording their food intake. There are other measured outcomes (such 
as high protein and low calcium intake from the PD) in the evaluated studies that were consistently 
significant but not discussed in this systematic review. These outcomes should be further researched to 
find out if such dietary intake will adverse effects that outweigh the possible significant benefits of the 
Paleolithic diet. However, the PD currently has enough evidence to be an option for medical providers to 
discuss with their diabetic, obese, or cardiovascular disease patients without contraindications. In 
addition to exercise and avoidance of environmental toxins, the PD option may be able to significantly 
improve the health and quality of life in these chronic disease patients compared to other diet 
alternatives. 
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TABLES 
 
 
Table I. GRADE Assessment: Characteristics of Reviewed Studies 
Design Included Outcomes 
Downgrade Criteria 
Quality 
Limitations Indirectness Imprecision Inconsistency Publication bias likely 
Lindeberg et al (2007)9 and  Jönsson et al (2010)10 
 
RCT 
 
Weight, Waist circumference, Fasting plasma glucose, HgbA1C, 
Cholesterol, Satiety 
Serious 
limitationsa 
No serious 
indirectness 
No serious 
imprecision 
No serious 
imprecision 
 
No bias 
likely 
 
Moderate 
Jönsson et al (2009)11 
Randomized 
Crossover Trial 
Weight, Waist circumference, Fasting plasma glucose, HgbA1C, 
Cholesterol, HDL, LDL, TG, SBP, DBP 
Very serious 
limitationsa,b 
No serious 
indirectness 
Serious 
imprecisionc 
No serious 
imprecision 
No bias 
likely Very low 
Mellberg et al (2014)12 
RCT Weight, Waist circumference, Fasting plasma glucose, Cholesterol, HDL, LDL, TG, SBP, DBP 
Very serious 
limitationsa,d 
No serious 
indirectness 
No serious 
imprecision 
No serious 
imprecision 
No bias 
likely Low 
a Lack of mention of blinding of the researchers who were collecting the data 
b 
Failure to fully account for carry-over effect and lacked a wash-out period 
c 
Small sample size 
d 
Large percentage of attrition in both study groups 
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Table II. Summary of Findings 
e 
Need not apply as study does not include the pertaining data. 
f Author states “that there was no decrease blood pressure” in study patients. No data was shown in article pertaining to decrease in blood pressure within or between study groups. 
g 
Quotient of mean change in satiety during meal (RS) and mean energy from food and drink per meal (MJ). 
h 
Data involving outcome variables after patients switched diets at 3 months from baseline was not included in this summary table. The focus of this summary is to compare effects of the diets on the outcome variables without having to take into account for 
crossover effects that would be applicable 3 to 6 months from study baseline. 
i 
P-value is not significant.  
 Number of Patients   
 
 Outcomes: Comparing changes in outcomes between diets (Significant p-values <0.05) 
Study 
Treatment 
Group = 
Paleolithic Diet 
(PD) 
Comparison Diet 
(CD) 
Patient Population 
 
 
Study 
Length 
 
Weight Waist Circumference 
Fasting 
Plasma 
Glucose 
HgbA1C Cholesterol 
 
HDL 
 
 
LDL 
 
 
Triglycerides 
 
SBP 
 
DBP 
 
 
Satiety 
Lindeberg 
et al 
(2007)9 
and  
Jönsson  
et al 
(2010)10 
 
 
 
 
 
 
n = 14 
 
(Mediterranean-
like Diet, AKA 
Consensus Diet) 
 
n = 15 
Men with ischemic 
heart disease, 
waist 
circumference >94 
cm, and known 
diabetes or 
increased blood 
glucose 
 
 
 
 
 
 
 
12 weeks 
 
 
 
Change 0-12 weeks 
kg 
 
cm 
 
mmol/l % mg  
 
 
 
 
 
 
N/Ae 
 
 
 
 
 
 
 
N/A 
 
 
 
 
 
 
 
N/A 
 
 
 
 
No decrease in blood pressure 
within study groups.f 
RS/MJg 
 
PD = -5.0 
+/- 3.3 
 
PD = -5.6 +/- 2.8 
 
 
PD = -1.7 
+/- 1.7 
 
 
PD = -0.13 
+/- 0.26 
 
 
PD = 397 +/- 192 
 
 
PD = 2.5 +/- 
1.3 
 
 
CD = -3.8 
+/- 2.4 
 
CD = -2.9 +/- 3.1 
 
 
CD = -0.9 
+/- 1.8 
 
 
CD = -0.03 
+/- 0.39 
 
 
CD = 295 +/- 
122 
 
 
CD = 1.6 +/- 
0.5 
 
p = 0.3 
 
p = 0.03 
 
p = 0.2 p = 0.4 p = 0.11 p = 0.03 
Jönsson 
et al 
(2009)11 
 
(Paleolithic 
Diet first 3 
months) 
 
 n = 7 
 
 
(Diabetes Diet 
first 3 months) 
 
 
n = 6 
 
Men and women 
with Type 2 DM 
without insulin 
treatment 
 
 
 
 
 
 
 
 
 
 
6 months 
(Crossover 
study) 
 
 
Change from 0-3 months (Change at end of 1st diet from baseline)h 
kg cm 
 
mmol/l 
 
% 
 
mmol/l 
 
mmol/l mmol/l mmol/l mmHg mmHg  
 
 
 
 
 
 
 
 
 
N/A 
 
BL = 87 +/-
17 
 
BL = 103 +/- 14 
 
BL = 7.8 +/- 
1.2 
 
 
 
BL =  6.6 +/- 
0.6 
 
BL = 4.4 +/- 1.1 
 
BL = 
1.28 +/- 
0.22 
 
BL = 2.9 
+/- 0.9 
 
BL = 1.5 +/- 0.7 
 
BL = 150 +/- 
21 
 
BL = 83 +/- 
10 
 
PD = 81 +/- 
13 
 
 
PD = 94 +/- 9 
 
 
PD = 7.0 +/- 
1.4 
 
 
 
PD = 5.5 +/- 
0.7 
 
 
 
PD = 4.3 +/- 1.2 
 
 
PD = 
1.34 +/- 
0.30 
 
 
PD = 
2.7 +/- 
1.0 
 
 
 
PD = 1.0 +/- 0.5 
 
 
 
PD = 140 +/- 
12 
 
 
 
PD = 79 +/- 6 
 
 
CD = 84 +/- 
15 CD = 98 +/- 11  
 
CD = 7.5 +/- 
1.4 
 
 
CD = 5.9 +/- 
0.9 
 
 
CD = 4.5 +/- 1.2 
 
 
CD = 
1.26 +/- 
0.23 
 
 
CD = 
2.8 +/- 
1.1 
 
 
CD = 1.5 +/- 0.7 
 
 
CD = 149 +/- 
22 
 
 
CD = 83 +/- 
9 
 
p = 0.01 
 
p = 0.02 
 
p = 0.08 
 
p = 0.02 
 
p = 0.3 
 
p = 0.03 
 
p = 0.5 
 
p = 0.003 
 
p = 0.13 
 
p = 0.03 
 
Mellberg 
et al 
(2014)12 
 
 
 
 
n = 35 
 
 
NNR Diet 
 
n = 35 
Obese, 
postemenopausal, 
non-smoking 
women 
 
 
 
 
 
24 months 
kg 
 
cm 
 
mmol/l N/A mmol/l mmol/l mmol/l mmol/l mmHg mmHg  
 
 
 
 
 
N/A 
P value between study groups regarding change in outcome variables at 6 months from baseline 
 
p = <0.001 
 
p = <0.01 
 
p = NSi 
 
N/A 
 
p = NS 
 
p = NS 
 
p = NS 
 
p = <0.001 
 
p = NS 
 
p = NS 
 
P value between study groups regarding change in outcome variables at 24 months from baseline 
 
p = NS p = NS 
 
p = NS 
 
N/A p = NS 
 
p = NS 
 
p = NS 
 
p = 0.004 p = NS 
 
p = NS 
 
